To assess the safety and efficacy of intrathecal administration of 17.5 mg Bupivacaine heavy (0.5%) and 26.25 mg Ropivacaine (0.75%) for orthopedic lower limb surgeries.

Abstract

Background & Methods: The aim of the study is to assess the safety and efficacy of 
intrathecal administration of 17.5 mg Bupivacaine heavy (0.5%) and 26.25 mg Ropivacaine 
(0.75%) for orthopedic lower limb surgeries. The patients were belonging to physical status I 
and II as per ASA classification. The patients included in this study were from a wide range 
of age group 20 to 40 year of age and both sexes schedule for various operation for 
orthopaedic lower limb surgeries. 30 patients were divided into 2 groups of 15 each. Group I 
received Bupivacaine 17.5 mg and group II received Ropivacaine 26.25 mg. All the patient 
included in the study well subjected to through preoperative clinical examination in order to 
rule out any systemic disease. All the patients were monitor for NIBP, HR, SPO2 & ECG 
continuously till the end of surgery. Assessment of sensory block was done by pin prick and 
motor block using a modified Bromage score.